Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Other Accumulated Expenses (2023 - 2024)

Historic Other Accumulated Expenses for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q2 2024 value amounting to $3.7 million.

  • Connect Biopharma Holdings' Other Accumulated Expenses rose 1698.53% to $3.7 million in Q2 2024 from the same period last year, while for Jun 2024 it was $3.7 million, marking a year-over-year increase of 1698.53%. This contributed to the annual value of $3.0 million for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q2 2024, Connect Biopharma Holdings' Other Accumulated Expenses is $3.7 million, which was up 1698.53% from $3.0 million recorded in Q4 2023.
  • Connect Biopharma Holdings' 5-year Other Accumulated Expenses high stood at $3.7 million for Q2 2024, and its period low was $3.0 million during Q4 2023.